KLH: Clinical Trials

3 trials of KLH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 11Completed 1

Follow KLH: new trials by email Literature Review of KLH trials Research Report on KLH

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Bevacizumab, Rindopepimut (CDX-110) with GM-CSF, KLH - Glioblastoma, Small Cell Glioblastoma
Phase 2CompletedCelldex Therapeutics1272011-12-012020-02-17
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
WT1 Peptide-Pulsed Dendritic Cells, Donor Lymphocytes, IL-4 - Leukemia, Acute Myelogenous (AML), Leukemia, Acute Lymphocytic (ALL)
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)102008-02-222017-04-12
Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome
Bacteriophage, rhuCD40L, KLH - Immunoproliferative Disorder
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)51999-10-012008-03-04

Conditions studied

Brain Neoplasms (1)  ·  Glioblastoma (1)  ·  Gliosarcoma (1)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Primary Immunodeficiency Diseases (1)  ·  Recurrence (1)

Sponsors

Celldex Therapeutics (1)  ·  National Cancer Institute (NCI) (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (3)

Top investigators

Terry J Fry, M.D. (1)

Results publications

PMID 26670466, PMID 32034072